Detalhe da pesquisa
1.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Int J Cancer
; 150(8): 1341-1349, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34807464
2.
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Lancet
; 393(10184): 1948-1957, 2019 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30982686
3.
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Hematol Oncol
; 38(3): 244-256, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067259
4.
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Cancer Immunol Immunother
; 68(5): 799-812, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770959
5.
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial.
Ann Hematol
; 98(4): 897-907, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610279
6.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica
; 101(11): 1398-1406, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27662018
7.
Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6.
Blood
; 121(22): 4493-503, 2013 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23603913
8.
The efficiency of human cytomegalovirus pp65(495-503) CD8+ T cell epitope generation is determined by the balanced activities of cytosolic and endoplasmic reticulum-resident peptidases.
J Immunol
; 189(2): 529-38, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22706083
9.
NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability.
Int J Cancer
; 132(6): 1360-7, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22907642
10.
Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
FEBS J
; 290(17): 4256-4267, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37097223
11.
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease.
Int J Cancer
; 130(10): 2327-36, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21717461
12.
Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer.
Nat Med
; 8(6): 631-7, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12042816
13.
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial.
Cancers (Basel)
; 13(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638344
14.
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.
Leukemia
; 35(3): 809-822, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32684633
15.
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Blood Cancer J
; 11(1): 1, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414374
16.
Use of tumour-responsive T cells as cancer treatment.
Lancet
; 373(9664): 673-83, 2009 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19231634
17.
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).
Oncoimmunology
; 9(1): 1806680, 2020 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923171
18.
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial.
Leukemia
; 34(7): 1853-1865, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034285
19.
Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.
Int J Cancer
; 125(3): 649-55, 2009 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19444908
20.
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
J Clin Oncol
; 36(20): 2024-2034, 2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29750632